Acute Pancreatitis in a Patient Taking Semaglutide

The Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) trial showed that semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is effective in managing type 2 diabetes by stimulating insulin secretion and promoting weight loss. Though recent evidence s...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Femina, Gan, Arnold, Chang, Karen, Vega, Kenneth J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506915/
https://www.ncbi.nlm.nih.gov/pubmed/37731423
http://dx.doi.org/10.7759/cureus.43773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506915/
https://www.ncbi.nlm.nih.gov/pubmed/37731423
http://dx.doi.org/10.7759/cureus.43773

Ejemplares similares